Challenges of shared decision-making by clinicians and patients with low-risk differentiated thyroid cancer: A systematic review and meta-ethnography

W Yang, YK Lee, P Lorgelly… - … –Head & Neck Surgery, 2023 - jamanetwork.com
Importance Several international guidelines have endorsed more conservative treatment of
low-risk differentiated thyroid cancer (LRDTC), yet patients are facing more treatment …

Differences in the knowledge, attitudes, and needs of caregivers and healthcare providers regarding palliative care: a cross-sectional investigation in pediatric settings …

X Lin, G Qulian, Y Bai, Q Liu - BMC nursing, 2024 - Springer
Background Countries abroad have implemented pediatric palliative treatment for several
years; however, complete pediatric palliative treatment guidelines and legal guidance …

Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha and beta testing

A Koot, R Hermens, P Ottevanger… - Frontiers in …, 2023 - frontiersin.org
Background Patient decision aids (PtDAs) are structured clinical tools that facilitate shared
decision-making. Two important treatment decisions for patients with differentiated thyroid …

Fear of cancer Recurrence Despite a good prognosis: A Qualitative study with Thyroid Cancer Patients

G Lu, W Luo, J Lin, N Xu, C Zheng - 2023 - researchsquare.com
Objective: Thyroid cancer's emotional and mental toll is often beyond the disease's duration.
The fear of cancer recurrence (FCR) was prominent among cancer patients and survivors …

Present and future of personalised medicine for endocrine cancers

CL Ronchi, B Altieri - Journal of Personalized Medicine, 2022 - mdpi.com
Major technological advances in genomics have made it possible to identify critical genetic
alterations in cancer, rendering oncology well along the path to personalised cancer …